MN-DIGI-INTERNATIONAL
7.11.2022 14:01:45 CET | Business Wire | Press release
Digi International® (NASDAQ: DGII), a leading global provider of Internet of Things (IoT) connectivity solutions, today unveiled the Digi XBee® RR, a wireless networking module to support IoT solutions within the XBee ecosystem. Digi XBee RR offers immediate availability and dramatically reduces time-to-market for designers, OEMs, and solution providers by providing off-the-shelf, pre-certified wireless connectivity and easy-to-add functionality. For customers needing immediate assistance in transitioning to this available module, Digi is also offering its Digi XBee Rapid Redesign Services.
Building on industry-leading technology, the low-power, low-profile Digi XBee RR module gives designers the ability to switch among multiple frequencies and wireless protocols with a fully interoperable Digi XBee ecosystem to support a range of applications spanning building automation, smart energy, digital health, intelligent lighting, and more.
Immediately Available Module Opens Up Product Development Options
Digi XBee RR modules are in stock and available to order today for immediate delivery from Digi's global distributor network. The XBee RR line includes modules with different form factors, wireless protocols and antenna options to provide an easy transition from existing XBee 3 designs.
“The release of our XBee RR gives engineers and developers an immediately available, pre-certified wireless module in what has been a very difficult, component-constrained environment,” said Steve Ericson, Vice President and General Manager of Digi’s OEM Solutions division. “In addition to the available-now Digi XBee RR, Digi has its IX15 gateway and Digi Remote Manager®, providing developers a complete device-to-cloud IoT solution.”
From edge computing to future migration, the size, weight, power, and performance advantages of Digi XBee RR are ideal for scalable device connectivity. With Digi Remote Manager, it’s easy for network managers to configure, monitor, and control Digi XBee RR modules via a gateway from a simple, central platform. Built-in Digi TrustFence® security, identity, and data privacy features tap into more than 175 controls to protect against new and evolving cyber threats. Digi XBee Mobile App and Digi XCTU® software tools simplify setup, configuration, testing, and adding/changing functionality.
Expert Help Available to Speed Time-to-Market
To fully support customers with Digi XBee RR design, Digi Wireless Design Services is offering a Digi XBee Rapid Redesign Service. These services include design consultation, customized transition plan for replacing an existing embedded module, and testing for unintended EMI produced.
The Digi XBee ecosystem’s software, gateways, and cloud connectivity deliver unparalleled support for short-range networking systems with ZigBee®, 802.15.4 and Digi’s patented DigiMesh® protocols, as well as Bluetooth provisioning.
Digi XBee RR is available now. For more information, visit: https://www.digi.com/xbee-rr
About Digi International
Digi International (NASDAQ: DGII) is a leading global provider of IoT connectivity products, services, and solutions. It helps companies create next-generation connected products and deploy and manage critical communications infrastructures in demanding environments with high levels of security and reliability. Founded in 1985, Digi has helped customers connect more than 100 million things and counting. For more information, visit www.digi.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221107005014/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom